Sampeginterferon beta-1a

Modify Date: 2024-04-06 19:08:29

Sampeginterferon beta-1a structure	Common Name	Sampeginterferon beta-1a
	CAS Number	1796570-07-4	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Sampeginterferon beta-1a

Sampeginterferon beta-1a (BCD-054) is a pegylated IFNβ-1a. Sampeginterferon beta-1a can be used for research against remitting multiple sclerosis[1][2].

Name	Sampeginterferon beta-1a

Description	Sampeginterferon beta-1a (BCD-054) is a pegylated IFNβ-1a. Sampeginterferon beta-1a can be used for research against remitting multiple sclerosis[1][2].
Related Catalog	Research Areas >> Others Signaling Pathways >> Others >> Others
References	[1]. Boyko AN, et al. Novyĭ pegilirovannyĭ interferon beta-1a (sampéginterferon beta-1a, BCD-054) v terapii remittiruiushchego rasseiannogo skleroza [The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):100-109. Russian. [2]. Boyko A N. Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a)[J]. Neurology, Neuropsychiatry, Psychosomatics, 2022, 14(1S): 34-37.

Description

Sampeginterferon beta-1a (BCD-054) is a pegylated IFNβ-1a. Sampeginterferon beta-1a can be used for research against remitting multiple sclerosis[1][2].

Related Catalog

Research Areas >> Others

Signaling Pathways >> Others >> Others

References

[1]. Boyko AN, et al. Novyĭ pegilirovannyĭ interferon beta-1a (sampéginterferon beta-1a, BCD-054) v terapii remittiruiushchego rasseiannogo skleroza [The new pegylated interferon beta-1a (sampeginterferon beta-1a, BCD-054) in the treatment of remitting multiple sclerosis]. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(10. Vyp. 2):100-109. Russian.

[2]. Boyko A N. Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a)[J]. Neurology, Neuropsychiatry, Psychosomatics, 2022, 14(1S): 34-37.

No Any Chemical & Physical Properties

Sampeginterferon beta-1a

Use of Sampeginterferon beta-1a

Names

Sampeginterferon beta-1a Biological Activity

Chemical & Physical Properties